• Home
  • Contact Us
  • Try it!
  • Blog
  • Vizit Graphs

Follow us

Recent Posts

  • Business Development Agent in Japan February 12, 2020
  • High Throughput Layout and Copy Paste July 5, 2019
  • Biovista in World’s Top 20 AI Drug Development Companies March 22, 2019
  • Biovista signs EU-IMI2 research agreement to advance neurotoxicity de-risking in preclinical drug discovery March 15, 2019
  • The increasing importance of predicting AEs & the role of Augmented Intelligence September 10, 2018

Biovista Vizit

Biovista Vizit

  • Try it!
  • Blog
  • Vizit Graphs

REMICADE

TNF inhibitors and the microbiome

August 24, 2018Autoimmune Diseases, Microbiome, Vizit Graphs
TNF inhibitors and the microbiome

Study microbiota of patients treated with TNF inhibitors with Biovista Vizit. Explore the live graph.

Hepatitis and Autoimmune Diseases Drugs

August 24, 2018Autoimmune Diseases, Hepatitis, Vizit Graphs
Hepatitis and Autoimmune Diseases Drugs

Managing infections and autoimmunity with Remicade and Ribavirin. Explore the live graph.

Vizit Graphs Tag Cloud

CELL PROLIFERATION RECEPTOR INSULIN IL23A CASP3 CLOSTRIDIUM DIFFICILE BREAST CANCER PORPHYROMONAS GINGIVALIS STAPHYLOCOCCUS AUREUS DIABETES MELLITUS ESCHERICHIA COLI APOPTOTIC PROCESS LISTERIA MONOCYTOGENES NEURODEGENERATIVE DISORDERS FOXP3 IMMUNE RESPONSE CELL DEATH CTLA4 TNF CELL DIFFERENTIATION INFLAMMATION AUTOPHAGY HELICOBACTER PYLORI ALZHEIMER'S DISEASE CD4 AGING ERBB-2 IL6 DOXORUBICIN SOD1 ANGIOGENESIS IL17A CELL DIVISION PSEUDOMONAS AERUGINOSA 1-METHYL-4-PHENYL-1-2-3-6-TETRAHYDROPYRIDINE IFNG RHEUMATOID ARTHRITIS METFORMIN TP53 PARKINSON DISEASE CANCER CANDIDA ALBICANS STREPTOCOCCUS PNEUMONIAE TH17 CELLS REMICADE

© 2020 Biovista Vizit All Rights Reserved.